the only feature distinguishing prostatodynia from nonbacterial prostatitis is the absence of an inflammatory reaction in the EPS of patients with prostatodynia.
Acute and chronic bacterial prostatitis
In acute bacterial prostatitis, the infection often begins with malaise, fever and myalgias several days before local prostatic inflammation produces symptoms of urinary frequency, urgency, dysuria, and ultimately obstructive voiding. On rectal examination, the prostate is often -but not always -hard, irregular, and may even be suggestive of prostatic cancer; these rectal findings gradually return to normal with subsidence of the inflammation. In chronic bacterial prostatitis, by contrast, symptoms are limited to those associated with bacteriuria; the prostate feels normal on rectal palpation and is equally unremarkable at endoscopy. Both acute and chronic bacterial prostatitis can be associated with reinfections of the prostate when patients are followed for several years after obtaining bacteriological cures. Failure to cure chronic bacterial prostatitis, which occurs in about half of our patients, is followed by bacteriuric recurrences with the same organism at time intervals of 48 hours to six months after stopping antimicrobial therapy (Stamey 1980) . While the infecting bacteria are most commonly E. coli and other members of the Enterobacteriaceae family, Pseudomonas aeruginosa and enterococci also cause prostatic infections in the absence of hospitalization or catheterization. The incidence of acute and chronic bacterial prostatitis is unknown, but it is relatively rare since recurrent bacteriuria in males is most uncommon. Moore (1937) studied 581 unselected prostates at autopsy from men between 20 and 90 years of age; each prostate was studied microscopically in 4 ml step-sections for the presence of inflammation. Thirty-six (6.3%) showed typical histological changes of acute or chronic inflammation, 26 of which were considered clear examples of ascending prostatic ductal inflammation. The incidence of inflammation was related to increasing age, with 16.3% of patients aged 81-90 years showing such changes. Moore also called attention to several noninfectious causes of cellular infiltrate including sclerotic atrophy and ductal obstruction. The classic studies of McNeal (1968 McNeal ( , 1972 , who divided the true prostate (as opposed to the periurethral elements of benign hyperplasia) into the central and peripheral zones, showed a substantially greater frequency of inflammation in the peripheral zone. Blacklock (1974) has pointed out the anatomical and functional factors which theoretically might allow greater involvement of the peripheral zone in an ascending infection. When acute bacterial prostatitis is associated with an irregular, stony-hard prostate suggestive of cancer, prostatic biopsy usually shows a granulomatous reaction in the tissues (Stamey 1980 , Kelalis et al. 1965 .
Diagnosis' of chronic bacterial prostatitis: Acute bacterial prostatitis is so dramatic in its presentation that the diagnosis is obvious once the systemic manifestations become associated with lower urinary tract symptoms. In contrast, chronic bacterial prostatitis is asymptomatic in between episodes of recurrent bacteriuria. In 1965, Stamey et al. reported the value of segmenting the voided urinary stream into urethral (VB\ : voided bladder one), midstream (VB 2 : voided bladder two), and post-prostatic massage (VB 3 : voided bladder three) aliquots in order to separate urethral from prostatic infection in the presence of a sterile, midstream urine. However, Meares & Stamey (1968) documented the importance of a direct culture of the EPS when the VB l and VB 3 aliquots were equivalent in bacterial numbers and, of equal importance, emphasized the usefulness of antibacterial therapy -especially nitrofurantoin and oral penicillin G as a diagnostic tool in clearing the uretha of prostatic organisms; the reproducibility of these culture techniques was demonstrated in longitudinal studies of patients with recurrent bacteriuria. Figure I illustrates the culture technique, and several diagnostic examples, both on and off antimicrobial therapy, are presented in Table 2 . Longterm follow ups of ten years or more on many of these patients have been published recently (Stamey 1980) . All of our reports from Stanford, including the therapeutic trials of Meares (1973a Meares ( , 1975 . have been on patients with recurrent bacteriuria due to strains of Enterobacteriaceae, pseudomonas or enterococci. However, Drach (1974) , using the same Figure I , reported a very high proportion of Gram-positive organisms (37% Staphylococcus epidermidis, 21% z-streptccocci and 12% diphtheroids) in 153 localizations in 85 patients -organisms that we consider are urethral contaminants of EPS. Drach, basing his conclusions on extraordinarily low numbers in VB 3 and EPS bacterial counts from 74 normal controls, believes that 5000 bacteriajml or more in the EPS or VB 3 is diagnostic of prostatitis, provided the 'VB) and VB 2 contain fewer than 3000 organisms per ml'. Since he also believes that these normal urethral organisms do not cause bacteriuria, it is clearly impossible to show the longitudinal reproducibility of recurrent bacteriuria with interim persistence of Gram-positive bacteria in the prostate in the same convincing way that Meares and I have done with Enterobacteriaceae. For example, there are no data with nitrofurantoin or oral penicillin G to show sterilization of the urethra with positive EPS or VB 3 cultures, despite. the fact that these two antimicrobial agents are even more ideal for urethral S. epidermidis than for urethral E. coli. Lastly, Drach's contention that transurethral resection biopsies of the prostatic urethra grow S. epidermidis in no way excludes urethral contamination of the biopsy. As will be seen later, it is likely that antigen-specific antibodies in the EPS will ultimately prove whether Drach's data represent urethral contaminants or true prostatic infection. There is another important point about diagnosis. When pathogenic bacteria are on the urethral mucosa, the rise in bacterial numbers in the VB 3 and the EPS must be in such excess over the numbers in the VBI that there can be little doubt that the few ml of sterile bladder urine (the VB 3 ) to traverse the prostatic, bulbar and penile urethra after massage did not pick up these organisms from the urethra. The bacterial numbers in the VB! and VB 3 depend upon such variables as the volume of sterile bladder urine used to collect the specimens; whether the initial ml or two of urine is missed because of a dispersed or splayed urinary stream; whether the VB! and VB 3 are nearly equal in volume; and, of course, how many bacteria are obtained from the prostate during massage. Because of these variables, there are no solid data as to how much the bacterial count must rise in the EPS or VB 3 in comparison to the VB! in order to diagnose bacterial prostatitis. Our data suggest that at least a ten-fold increase should be present and IOO-fold increase is, of course, even more indisputable (Table 2) . It is because of this uncertainty that nitrofurantoin and oral penicillin G are so useful in removing all urethral organisms and thereby leaving the presence of almost any bacteria in the EPS or VBj as indisputable evidence of prostatic infection.
Rationally, a comparison of Vb, and VB 3 specimens is a better way to make the diagnosis because the urethral bacteria face the same mechanics of sterile urine washing across the urethral mucosa in which prostatic massage is intervened between the two voidings. While the collection of EPS between the VB! and VB 3 is often necessary to make the diagnosis due to the very small numbers of bacteria in prostatic fluid, and also necessary because the prostatic secretion is often diluted 100-fold by the VB 3 urine, the addition of urethral bacteria to the EPS sample simply cannot be controlled in the same sense as the VB! serves as a control for the VB 3 • I believe that it is possible that the viscosity of prostatic secretion, and perhaps the way it slowly moves along the urethral mucosa or perhaps hangs in the fossa navicularis before falling free into the collection vessel, adsorbs far more diphtheroids, lactobacilli, and Gram-positive cocci than the corresponding VB 3 washes from the urethra. For example, localization studies from healthy control men who were without symptoms or microscopic evidence of prostatic inflammation are shown in Table 3 . One can observe that by the VB 1-VB3 technique, the bacteria are urethral in origin, but by the VB!-EPS comparison, examples 2, 3, 4A and 5 would be considered prostatic organisms. Since surely they are urethral, it must be concluded that EPS can adsorb more normal urethral bacteria than the VB 3 urine and that this mechanism may possibly account for the extraordinary percentage of Gram-positive localization in the studies by Drach (1974) . For those few patients in whom one cannot obtain EPS or even a cloudy VB 3 , cultures of the seminal fluid can be obtained by ejaculation as advocated by Mobley (1975) . When a VB! culture has been compared with the ejaculate semen culture, the bacterial count of normal urethral organisms is often 10 to 100 times higher than the count in the VB! specimen. Thus, while this technique is probably reliable for Gram-negative bacteria, it could be very misleading if such bacteria were present on the urethra prior to ejaculation. It is highly likely that the massage of the distal urethra which accompanies masturbation produces far more normal urethral bacteria into the urethral lumen to be picked up by the seminal fluid at the time of ejaculation than occurs in the normal voiding of a VBI aliquot. This disadvantage could perhaps be offset by demonstrating a sterile VB1 from nitrofurantoin or oral penicillin G therapy immediately prior to ejaculation.
Nonbacterial prostatitis
Nonbacterial prostatitis is characterized by a variety of pelvic symptoms which in general may be urinary, ejaculatory, or referred pain. The pain may be suprapubic, infrapubic, perineal, inguinal, scrotal, or low back discomfort. These patients, however, never have bacteriuria and the cause of the inflammatory reaction in the EPS of patients with non bacterial prostatitis is unknown. The inflammatory reaction in the EPS of most patients with nonbacterial prostatitis is indistinguishable with the light microscope from that of patients with acute and chronic bacterial prostatitis ( Figure 2A ). Even the oval fat macrophages (Figure 28 ) are equally characteristic of both types of inflammation. In a detailed and quantitative study by Anderson & Weller (1979) ,40 men with non bacterial prostatitis had a five-fold increase in the number of leukocytes in their EPS in comparison to 20 healthy control men; oval fat macrophages ( Figure 28 ) were increased eight-fold in these patients. While the incidence of non bacterial prostatitis is also unknown, it is an everyday clinical experience that this syndrome is many times more common than true bacterial prostatitis. Because of these substantial differences in prevalence, most of the literature on 'prostatitis' undoubtedly relates to either non bacterial prostatitis or to prostatodynia. But unfortunately, even in the more careful studies carried out by the University of Lund group in Sweden , their term 'non-acute prostatitis' also included some patients who probably had chronic bacterial prostatitis. A careful review of their excellent contributions leaves little doubt that almost all of their patients actually had non bacterial prostatitis and therefore their contributions to the aetiology of this condition are considered in some detail. Moreover, , recognizing the difficulty of accurate diagnosis because of urethral contamination of EPS, wisely compared their bacteriological findings to those in 20 healthy, normal volunteers; in their search for aerobes, strict anaerobes, mycoplasmas, fungi, trichomonads and viruses, they found no greater incidence in their patients than in their controls. These authors concluded that 'the cultures of the expressed prostatic fluids and the samples of semen gave no information of the occurrence of bacteria over and above that obtainable from examination of the urethral specimens'. Our own attempts at Stanford to prove neisseria, Ureaplasma urealyticum, aerobic and anaerobic bacteria were unsuccessful (Meares 1973b) .
In a later report, Mardh and his associates (1978) appear to have excluded Chlamydia trachomatis as an aetiological agent in nonbacterial prostatitis. Since C. trachomatis is recognized as the cause of nongonococcal urethritis in 40% of cases (Holmes et al. 1975) , as well as the major cause of acute epididymitis in men under 35 years of age (Berger et al. 1978) , this intracellular agent was an excellent candidate for the causative organism in nonbacterial prostatitis. Gordon et al. (1972) and Nielsen & Vestergaard (1973) were unable to isolate viruses as an aetiological agent from either urine, EPS, or prostatic biopsies in patients with prostatitis. Nielsen & Justesen (1974) also failed to incriminate obligate anaerobes in the urine, EPS, or in prostatic biopsies; they showed the importance of culturing the perineal skin to control for contamination of the perineal needle biopsies of the prostate. In another study, performed transperineal needle biopsies of the prostate on 18 patients with chronic 'prostatitis' and compared them to biopsies in 18 patients with chronic urethritis; interestingly, there was as much prostatic inflammation in the urethritis group as was found in the patients with 'prostatitis'.
C-reactive protein in the serum was found in only six of 78 patients with chronic prostatitis ; these authors also observed that seminal fluid spermiograms were similar in controls and patients with prostatitis -an important observation for those who believe prostatitis affects male fertility. further observed no differences between patients and controls in respect of the concentration of zinc and magnesium in EPS. Fair et al. (1976) have clearly shown that zinc is substantially reduced in patients who have chronic bacterial prostatitis.
It is a clinical fact that patients with nonbacterial prostatitis do not respond to antimicrobial agents and it is clear that all efforts to prove the aetiology of the inflammatory reaction have been unsuccessful. It is possible that non bacterial prostatitis is caused by a chemical rather than an infectious agent. I have always been intrigued at how asymptomatic are men with true chronic bacterial prostatitis as long as their bladder remains uninfected. For example, despite years of demonstrating bacterial persistence of E. coli, P. aeruginosa or P. mirabilis in the EPS, these men have no urinary, ejaculatory, or pelvic pain as long as their bladder urine remains uninfected from continuous prophylactic therapy. Thus, if thousands and even tens of thousands of P. aeruginosa can persist in the EPS without symptoms, it is hard to imagine what kind of infectious agent must be present in patients with nonbacterial prostatitis to produce such devastating pelvic symptomatology. We must look for other causes. For example, could efflux of urine into the prostate produce an inflammatory reaction? Could prostaglandins from the seminal vesicles cause inflammation in the prostate?
Autoimmune disease of the prostate is frequently mentioned as a possibility, but there are simply no data to support this hypothesis.
Whatever the cause of nonbacterial prostatitis, treatment is most unsatisfactory . . My best results have occurred when I have encouraged patients that no one knows the cause of their inflammation, that it is unlikely to be an infectious agent, that antimicrobial agents are a waste of money, and that their symptoms will ultimately improve. I believe it is very important for the physician to recognize non bacterial prostatitis and to refrain from prescribing antimicrobial agents. The use of these agents, which are invariably ineffective, simply adds credence to a nonexistent infection which creates more anxiety for the patient, prolongs his misery, and strengthens his concern that there must be an underlying, mysterious infection which his physicians cannot cure.
Prostatodynia
As can be seen in Table I , prostatodynia is a term of exclusion and has little meaning beyond that of excluding an inflammatory response in the EPS in a man with pelvic symptoms identical to those found in patients with non bacterial prostatitis. Since the distinction between non bacterial prostatitis and prostatodynia depends exclusively upon the presence of inflammatory cells in the EPS, the number of leukocytes in normal EPS is of critical importance. Observations reported by Blacklock (1969) , Pfau et al. (1978) , and Anderson & Weller (1979) have led me to estimate that 12 WBC per high power field in a cover slip examination of EPS should include about 95% of all normal controls reported by these authors (Stamey 1980) . Anderson & Weller (1979) used a Fuchs-Rosenthal chamber to quantitate leukocytes in 20 carefully selected healthy control men; they reported that the upper limit of normal (2.5 standard deviations) is 1165 WBCs/mm 3 , a figure which translates to approximately 12 WBCs per high power field (Stamey 1980) . Thus, in the absence of better evidence, approximately 12 WBCs per high power field can be taken as the upper limit of normal for 95% of healthy men when EPS is examined under the standard cover slip preparation on a microscope slide. Quantitation, by Anderson & Weller's method (1979) , is clearly better.
There are two reasons to diagnose prostatodynia and separate this group of patients from those with similar symptoms but who have non bacterial prostatitis. The first reason is that many of these patients, as shown by Nilsson et al. (1975) , have evidence on psychiatric testing of psychotic tendencies, paranoid projections, and defects in sex identification. Thus, at least some of these patients should be referred to psychiatrists although we have no evidence that psychiatric counselling benefits this syndrome. The second reason is that there are occasional patients with prostatodynia who, along with their pelvic symptoms, also have a strong history of a poor urinary stream sometimes accompanied by hesitancy and intermittency. These patients may benefit from x-phenoxybenzamine, an alpha blocking agent, which can substantially improve their urine flow rate and sometimes their ejaculatory symptoms. It is well recognized that the ejaculatory organs of the male, especially the seminal vesicles, are mainly innervated by adrenergic nerves which also form a collar of preprostatic adrenergic tissue around the internal vesical neck of the bladder so that it closes at the time of ejaculation. It is possible that some patients with prostatodynia have increased adrenergic activity in their pelvis and, therefore, adrenergic blocking agents may be helpful. In my experience, 10 mg of z-phenoxybenzamine at bedtime is usually all that is required; 30'mg per day will produce retrograde ejaculation. Unfortunately, most patients I have seen with prostatodynia deny any symptoms suggestive of bladder neck obstruction and these patients have not responded in my hands to adrenergic blocking agents.
Antibacterial factor in prostatic fluid
During the course of our experimental studies at Stanford in the mid I960s on the diffusion of antimicrobial agents from plasma to prostatic fluid, we observed that canine prostatic fluid seemed remarkably sterile despite casual laboratory handling at room temperature. Because of this observation, we added E. coli (Table 4 ) and other Enterobacteriaceae (Table 5) to canine prostatic fluid; to our surprise these organisms were killed within a few hours. When we added the same bacteria to VB 2 and VB 3 urines obtained from normal human males, we observed a similar bactericidal activity in the VB 3 urine (which contained prostatic fluid) as had occurred in the canine prostatic fluid; the VB 2 aliquot supported growth of bacteria while the VB 3 specimen was bactericidal (Figure 3 ). We expanded these observations and identified the antibacterial factor as a low molecular weight, heat-stable substance inactivated by serum . We were unaware until much later that Youmans et al. (1938) , also investigating the bactericidal action of urinary antiseptics in dogs, had also observed and studied canine prostatic fluid for its antimicrobial activity. Fair and his coworkers (1976) at Stanford, in a laborious effort to identify the antimicrobial substance, have shown it to be a zinc salt; of equal importance, they have demonstrated that men with chronic bacterial prostatitis average about 50 JlgJml of zinc in their prostatic fluid compared with control levels in healthy volunteers of 450 JlgJml. They further observed that serum levels of zinc were normal in patients with chronic bacterial prostatitis and, what is often ignored in clinical practice, that oral exogenous zinc did not change the markedly depressed levels in the EPS of patients with chronic bacterial prostatitis. In an experimental extension of these data, Levy & Fair (1973) localized a similar activity in the EPS from the dorsolateral lobe of the rat's prostate. Friedlander & Braude (1972) observed that experimental urinary tract infections in the male rat were sustained by bacterial prostatitis which spared the dorsolateral lobe and mainly involved the ventral lobe where Levy and Fair found minimal antimicrobial activity. and 1800 E. coli/ml • The inoculum of 430 E. coli/ml was reduced to 30 E. coli/ml after 24 hours of incubation EPS has been shown by Gip & Molin (1970) to be inhibitory to Candida albicans. Human seminal fluid has also been shown to be inhibitory against some of the same bacterial species as in our work with EPS, but its activity does not seem to be as impressive as prostatic fluid alone (Tallgren et al. 1968) .
Immunological characterization of acute and chronic bacterial prostatitis Immunoglobulins IgG and IgA were reported by Chodirker & Tomasi (1963) in noninfected prostatic fluid; in 17 samples of EPS, they observed a mean concentration for IgA of 26 mg/IOO ml and for IgG of 157 mg/IOO ml. Gray et al. (1974) , using radial immunodiffusion agar plates, measured the total amount of IgG, IgA and IgM in EPS from 3 controls and 48 patients with prostatitis. About half of the patients studied had true bacterial prostatitis, the other half having nonbacterial prostatitis (Blacklock 1979, personal communication) . Although IgA was measured with antiserum raised against human serum, analysis by immunoelectrophoresis suggested that only secretory IgA was present in the normal reference group and the 'chronic cases'. In the normal group, there was a mean concentration of 38 mg/IOO ml of EPS for IgG, 12 mg/IOO ml for IgA, and 14 mgjlOO ml for IgM. Their patients with 'unresolved' prostatitis showed a three-fold increase in IgG (128 mg/IOO ml), a seven-fold increase In total IgA (85 mg/IOO ml) and two and a half-fold rise in IgM. In the patients whose prostatitis was thought to have resolved, IgG returned to normal levels but IgA and IgM remained at concentrations twice normal. These authors felt that the large increase of IgA over the normal level expected in EPS was a sensitive indicator of challenge by a foreign antigen (Gray et al. 1974) .
Using direct immunofluorescence of normal human prostatic tissue, Ablin et al. (1971) observed IgG and IgA in secretory granules lying within the ductular lumen; while IgG was seen in the basal portion of the cytoplasm of secretory epithelial cells, they were unable to show IgA in epithelial cells even though IgA was noted occasionally in plasma cells in the stroma.
We have modified a solid phase radioimmunoassay developed by Zollinger et al. (1976) to measure antigen-specific antibodies against a purified meningococcal antigen. Using formalinized whole E. coli isolated from the prostate as our antigen, we have followed patients longitudinally with acute and chronic bacterial prostatitis, measuring antigen-specific IgG and IgA antibodies in both their EPS and serum (Shortliffe et al. 1981) .
Immunoglobulin G The antigen-specific antibody (A-SA) response in the serum is mainly IgG in both acute and chronic bacterial prostatitis (Figure 4 with chills, dysuria, a temperature of lO2°F (39°C), and an E. coli 018 urinary infection; the right lobe of his prostate was stony hard, markedly elevated, and distorted on rectal examination. Immediate treatment with trimethoprim-sulfamethoxazole resulted in gradual softening of the prostate over the next three months. He remained free of further infections during the next 12 months of follow up. The patient with chronic bacterial prostatitis in Figures 4 and 5 was a 43-year-old man with an E. coli 075 asymptomatic urinary infection. His prostate felt anatomically normal on rectal examination. In late 1975 he had been seen with an E. coli 0 I bacterial prostatitis. After bacteriological localization of his E. coli 075 to the prostate while on nitrofurantoin, he was cured of his infection by 60 days of trimethoprim-sulfamethoxzole therapy and was followed at monthly intervals for six months. While the serum response in chronic bacterial prostatitis is clearly IgG, especially a few weeks after the infection has been cured, there is some antigenspecific IgA response, albeit a transient one (Figure 4) . The serum response of antigen-specific IgG antibodies appears diagnostic for both acute and chronic bacterial prostatitis.
Immunoglobulin A Figure 5 demonstrates that the major immunological response in prostatic fluid is antigenspecific IgA antibodies which exceed by many times the specific IgG response. Moreover, specific IgA antibodies remain strikingly elevated in the prostatic secretion ( Figure 5 ) long after such antibodies can no longer be detected in the serum (Figure 4) , an observation which strongly argues for local secretion of IgA
The titre of the EPS IgA antibodies also substantially exceeds the serum IgG titres. Thus, although the diagnosis of bacterial prostatitis can be made by measuring antigen-specific IgG antibodies in the serum (Figure 4) , it is clear that the titres of antigen-specific IgA antibodies in expressed prostatic fluid represent the most sensitive diagnostic index of this disease.
It is perhaps important to note that EPS from normal volunteers contains no detectable antigen-specific antibodies, neither IgG nor IgA, against the antigens of Enterobacteriaceae. For this reason, the measurement of antigen-specific antibodies in EPS is an extraordinarily sensitive indicator of chronic bacterial prostatitis. One drop of prostatic fluid is more than sufficient for these studies. Meares (1977 has reported bacterial agglutination titres in the serum of patients with chronic bacterial prostatitis, a technique that primarily measures IgM. In the patient with acute bacterial prostatitis caused by the E. coli 018 (Figures 4, 5) , serum agglutination titres changed from a dilution of 1 : 320 to a dilution of 1 : 160; in the patient with chronic bacterial prostatitis due to the E. coli 075 (Figures 4, 5) , serum agglutination titres were virtually undetectable at any dilution greater than I: lo. Serum and prostatic fluid agglutinins have also been reported in 60 patients against strains of staphylococci considered to be prostatic in origin (Maged & Khafaga 1965) , but bacteriological localizing data to the prostate were not presented.
Our data show that when antigen-specific antibodies are measured in patients with true bacterial prostatitis, the major response in the EPS is secretory IgA, and in the serum, IgG. It is also clear that changes in antigen-specific antibody far exceed any similar changes in total immunoglobulins.
Some therapeutic and pharmacological observations on treatment of chronic bacterial prostatitis
As we began to appreciate the therapeutic problems of chronic bacterial prostatitis in the early 1960s, especially the observation that sensitive bacteria were persisting in the prostate despite serum levels of bactericidal drugs which exceeded the minimal inhibitory concentration of the infecting organism by several-fold (Stamey 1980) , we suspected that our antimicrobiol agents were not penetrating into the prostatic fluid. While we did not know then, nor now, whether the site of bacterial persistence involved the interstitial area of the prostate, we were certain that some of the bacteria were in the secretory fluid because of our culture methodology. Accordingly, we explored the diffusion characteristics of antimicrobial agents from the plasma across the non-inflamed glandular epithelium of the canine prostate (Dunn & Stamey 1967 , Winningham et al. 1968 , Hessl & Stamey 1971 , Granato et al. 1973 ). We used a simple model in the dog where the ureters are separated from the bladder to prevent urinary contamination of prostatic secretions, the vas deferens is ligated from each testis to exclude secretions from that source, and the bladder neck ligated to close off the bladder secretions. After establishing plasma levels of antimicrobial agents by intravenous infusion, secretion of prostatic fluid was stimulated by intravenous pilocarpine in substantial doses which usually resulted in rapid prostatic fluid flow rates. The concentration of nine antimicrobial agents in plasma, urine and prostatic fluid, studied in 16 dogs, was first reported in 1968 (Winningham et al. 1968) . Representative results are shown in Table 6 -results which were at first confusing to us. It was clear that the first seven agents in Table 6 , the most useful antimicrobials available for treatment of Gram-negative urinary infections, were simply excluded from the prostatic fluid, an observation that certainly agreed with our clinical experience. On the other hand, we were perplexed by the diffusion, and even more perplexed by the concentration, of erythromycin and oleandomycin into prostatic fluid Plasma and prostatic fluid drug concentrations in the dog during infusion of 9 antimicrobial agents. Only erythromycin and oleandomycin were detectable in prostatic fluid. Note that prostatic fluid concentrations of these 2 antibiotics exceeded the plasma levels by 2 to 3 times at concentrations which exceeded the plasma levels. The infectious disease literature was not very helpful because the concentrations of antibiotics in tissues, with the exception of excretory organs like the liver and kidney, were determined by emulsifying the whole tissue; moreover, it was clear that the therapeutic basis of infectious disease depended largely on direct transfer of antimicrobial molecules from plasma into inflammatory areas where intact epithelial membranes were disrupted by inflammation. However, we were dealing with a different problem where the bacteria persisted on the secretory side of a presumably intact epithelial membrane and, from that secretory site, infected another major organ, i.e. the bladder and the kidney. While pondering these data during a sabbatical year in Oxford with Professor Paul Beeson, I soon learned the factors that determined the diffusion of weak acids and bases (all antimicrobial agents are one or the other) across epithelial membranes ( Figure  6 ). Lipid solubility was obviously important. Since only the uncharged portion of the lipidsoluble molecule can diffuse across the lipid membranes of epithelial cells, the pKa of the drug was critically important in determining the proportion of the molecules available in the uncharged form. The concentration of erythromycin in prostatic fluid, however, was explained by ion-trapping of the charged form of the molecule since the diffusable uncharged fraction redissociated in proportion to the higher hydrogen ion concentration in prostatic fluid (Figures 7 and 8) . A study of Figures 7 and 8 readily shows that when the secretory fluid is acid to plasma, as in the case of the canine prostate, antimicrobial bases will be ion-trapped in prostatic fluid whereas antimicrobial acids must be ion-trapped in plasma due to greater ionization in the more alkaline plasma side of the prostatic epithelium. Trimethoprim, a lipid-soluble base with a highly favorable pKa, became available early in England and was first studied in the canine model by Reeves & Ghilchick (1970) . We confirmed their studies (Granato et al. 1973) , and it is instructive to contrast the diffusion and ion-trapping of oleandomycin with trimethoprim. While oleandomycin in the prostatic fluid exceeds the plasma concentration during the first few ml of prostatic secretion (usually less than 8 ml), the concentration soon falls to one-third that of the plasma (Figure 9 ). Pilocarpine stimulation in trimethoprim-dosed dogs, however, is not only followed by trimethoprim levels which exceed the plasma by several-fold, but this difference is maintained in the presence of continuous secretion of prostatic fluid (Figure 10 ). This observation is undoubtedly accounted for by the difference in the number of uncharged molecules available for diffusion; with a pKa of 7.3, almost 50% of the trimethoprim molecules are in the uncharged form and available for diffusion across the prostatic epithelium. Oleandomycin, on the other hand, has a pKa of 8.5 with only 8% of the drug in the plasma in the un-ionized form. At the rapid flow rates of prostatic fluid induced by 25 mg doses of intravenous pilocarpine, it is probable that the 8% availability of oleandomycin for diffusion is too limiting for ion-trapping at such fast prostatic fluid flow rates. Baumueller & Madsen (1977) , however, obtained prostatic fluid from anaesthetized dogs by prostatic massage or by minimal doses of pilocarpine; in their reported studies with erythromycin, the prostatic fluid levels always exceeded the plasma concentration during continuous prostatic fluid collections. It would appear that if the prostatic fluid flow rate is sufficiently small, there is time for a drug with only 4% of its molecules in the uncharged form (erythromycin) to concentrate on the secretory side of the glandular epithelium. We were so impressed with the high concentrations of trimethoprim in canine prostatic fluid in comparison to the plasma levels (2 to 10 times greater) that we considered whether there might be an active transport system in the prostatic epithelium which pumped trimethoprim from plasma to prostatic fluid. Accordingly we sought to saturate such a transport system by loading the dog intravenously with increasing doses of trimethoprirn . In these experiments, arterial blood and prostatic fluid pH were closely monitored so that the theoretical diffusion gradients with ion-trapping could be calculated accurately. As seen in Figure 11 , the differences between prostatic fluid and serum concentrations of trimethoprim remained quite constant at steeply increasing serum levels without any suggestion that an active transport system was approaching saturation. Of equal importance, the concentration differences between prostatic fluid and serum (six-fold) were invariably less than the calculated theoretical ratio -which is how it should be. In any diffusion system across membranes of different pH, the actual concentrations found experimentally are always less than the theoretical because of factors such as protein binding, shifts in apparent pKa of the drug in complex biological fluids, lack of available time for full equilibrium, etc. Although an active transport mechanism was not found, I expect trimethoprim is the most diffusible antimicrobial agent in the history of chemotherapy. It surely is the most diffusible one with antibacterial activity against Enterobacteriaceae. Tissue concentrations of trimethoprim in the prostate measured in I!g!g exceed the simultaneous serum levels measured in I!g!ml , apparently due to the high concentrations of trimethoprim in prostatic fluid; in these canine studies, the prostatic tissue concentrations exceeded the serum level by about four-fold at a time when the prostatic fluid levels exceeded the serum concentration nine-fold. Interestingly, the levels in lung tissue also exceeded the serum by four-fold, virtually equivalent to the levels in the prostatic tissue . The mechanism of trimethoprim concentration in lung tissue is unknown, but presumably the bronchial secretions in these experiments must have been acid to plasma.
In human prostatic tissue, Dabhoiwala et al. (1976) measured trimethoprim concentrations in the prostate and plasma of patients undergoing prostatectomy; in those patients treated for one week before prostatectomy at standard dosage, the concentration of trimethoprim in homegenized prostatic tissue was 8.2 I!g!g compared to a mean plasma level of 4.0 I!gjml. In contrast, biologically active sulfamethoxazole concentrations in prostatic tissue were onethird that of the plasma -17 I!g!g compared to 48.7 Ilg!ml of plasma.
Meares (I 973a) treated 13 Stanford patients with trimethoprim-sulfamethoxazole (TMP-SMX) at a dosage of 160 mg TMP and 800 mg SMX twice daily for 14 days; two of the 13 patients were cured, with sterile monthly cultures six months after therapy; while an additional 9 patients had sterile EPS cultures while on therapy but the same organism recurred soon after completing treatment. Because of the apparent sterilization of the EPS during therapy in these 9 patients, 19 patients received full dosage therapy for 12 weeks (Meares 1975) ; 6 were cured (32%) while 8 had sterile EPS while on therapy, but infection recurred after treatment was discontinued. Four of these 19 patients, however, were failures from the initial14-day trial, which seemed to be an unfair bias towards failure; accordingly, if these four failures are excluded, the cure rate from the 12 weeks of therapy is 40% (Table 7) . Smith et al. (1979) randomized 30 male patients, all of whom had antibody-coated bacteria in their urine and half of.whom were proven to have prostatic infections, to either 10 days or 12 weeks ofTMP-SMX therapy; 9 of the 15 were cured on the 12-week course while 3 of the 15 were cured with the lO-day course for a P value difference of 0.06. These data suggest that a prolonged course of full dosage TMP-SMX for 12 weeks will cure about half of the patients with chronic bacterial prostatitis provided the infecting organism is sensitive to trimethroprim. If the infecting organism is recovered from the EPS during the first weeks of therapy, it is pointless to continue treatment.
Why the 40-60% failure rate? In the presence of prostatic calcifications, the bacteria could persist inside prostatic stones just as they do in renal struvite calculi (Stamey & Nemoy 1971) . Both Meares (1974) and Eykyn et al. (1974) have presented evidence that prostatic calculi can become secondarily infected. In such cases, however, the prostatic tissue per se is usually infected as well. Nevertheless, it is possible that secondary infection of these prostatic stones may prevent antimicrobial cure of the prostatic infection. However, since most patients with bacterial prostatitis do not have radiologically detectable calcifications, is it possible that the mucoprotein matrix of corpora amylacea -present in every prostate -could serve as a nidus of bacterial persistence in some of these patients?
Failure is clearly not due to development of bacterial resistance. Dr S R M Bushby at Burroughs Wellcome determined the minimal inhibitory concentration for each of the infecting strains causing bacterial prostatitis in the 15 patients who received TMP-SMX for 12 weeks. Analysis of these data showed that neither the cure, the improved group, nor the bacteriological failures could be explained by in vitro sensitivities. Except for the one naturally resistant P. aeruginosa, all of the infecting strains were sensitive to 0.5 Ilglml or less of TMP regardless of the bacteriological result; SMX resistance occurred in three of the six cures and in none of the four failures (Stamey 1980) . Moreover, there was no significant change in the sensitivity of the strains during or after therapy with TMP-SMX. Ludvik (1964) , Blacklock & Beavis (1974) , Pfau et al. (1978) have all shown that the pH of prostatic fluid is alkaline in the presence of inflammation (leukocytes) in the EPS, an observation also made by Young et al. in 1906 . With resolution of the inflammatory reaction, Blacklock & Beavis (1974) and Pfau et al. (1978) showed a fall in the alkaline pH to acid levels; both groups of investigators believe that EPS from normal, healthy men is acid (mean pH was 6.4 in Blacklock & Beavis' study). Anderson & Fair (1976) , collecting EPS from men who had not voided for several hours to avoid contamination with urine, reported a pH of 7.6 in older men (mean age 50 years). In a later paper, Fair and his colleagues (1979) argue that an alkaline pH to the EPS in patients with chronic bacterial prostatitis might explain the clinical failure of therapy with TMP-SMX. It is true that since trimethoprim (TMP) is a base, ion-trapping of TMP cannot occur in an alkaline EPS; but since 50% of the TMP molecules are uncharged in plasma, these un-ionized molecules should diffuse into the EPS and approximate the plasma level at equilibrium. For example, in Figure 11 the concentration of TMP in salivary fluid, which has a pH between 8 and 9, approaches the serum concentration ofTMP even though it cannot exceed it. Since the plasma concentrations ofTMP are not insignificant, about 1.7 ugjrnl ofTMP two hours after a dose of 160 mg TMP and 800 mg SMX, the concentration of uncharged TMP in even alkaline EPS should be at least 0.5 J..lg/ml. It should be noted that the minimal inhibitory concentration (MIC) ofTMP to all the 15 infecting strains treated for 12 weeks was 0.5 J..lg/ml or less except for the one strain of P. aeruginosa which should not have been included in the study; in fact, 10 of the 15 organisms had an MIC of 0.15 J..lg/ml (Stamey 1980) . A close examination of these MICs in relation to cures, improved, and failures show no relationship to whether the MIC was 0.15 or 0.5 J..lg/ml of TMP, all of which makes me doubt that the failures of TMP-SMX therapy were related to diffusion difficulties of TMP into an alkaline EPS.
An alkaline EPS in chronic bacterial prostatitis and a consideration of the diffusion consequences in Figures 7 and 8 , however, suggest that a lipid-soluble antimicrobial acid with a favorable pKa might be ion-trapped in EPS when it is highly alkaline (8.32 ±0.07 in the studies by Fair et al. 1979) at the height of the inflammatory response. This may explain the otherwise unexpected cures of bacterial prostatitis by sodium indanyl carbenicillin.
Thus, I believe that factors other than diffusion of TMP into EPS are responsible for the 40-60% failure rate of the 12-week course of therapy; my guess is that since sterilization of the EPS occurs in 75% of patients during therapy, bacteria are persisting in some focus within the prostate, perhaps the mucoprotein of the corpora amylacea, which the TMP cannot penetrate; nor is it likely that any other antimicrobial agent may do so.
Kanamycin therapy
When TMP-SMX therapy fails, a 10-14 day course of kanamycin is worthwhile. I reported one documented cure in 1972 (Stamey 1972) and Pfau & Sacks (1976) have added two others.
Prostatectomy
Transurethral resection of the prostate, which is the only operation short of total prostatectomy that has a chance to remove the non-hyperplastic tissue of the true outer prostate, has about a 33% chance of cure in our experience (Stamey 1980) . We documented, with multiple localizing cultures, the first reported cure of chronic bacterial prostatitis by transurethral resection in 1968 as well as the first documented cure by radical prostatectomy (Mears & Stamey 1968) . Smart & Jenkins (1973) reported that 72~~of patients were 'rendered asymptomatic' after transurethral resection, but there is no documentation that their patients had true chronic bacterial prostatitis; in a later paper, the same group reported that 50% of their patients were asymptomatic at follow up, but they relied on unquantitated tissuepositive broth cultures at the time of resection as evidence of chronic bacterial prostatitis (Smart et al. 1975) , some of which may have represented urethral or even urine contaminants. Without documenting data similar to that presented in Table 2 , it is simply impossible to know whether the prostate was infected or not in these or any other studies.
One reason why bacteriological cures from transurethral resection of the prostate, as opposed to total or radical prostatectomy, are unlikely to be much better than 33% is shown by McNeal's (1968) studies where most of the infection was to be found to be in the peripheral zone of the prostate; as emphasized by Blacklock (1974) , all of the ducts from the peripheral zone empty into the urethra distal to the verumontanum; a radical transurethral resection in this area carries a high risk of urinary incontinence. Nevertheless, for some patients who require a prostatectomy for other reasons than their recurrent infections, a transurethral resection may clearly be warranted.
Prophylaxis
Since many patients with chronic bacterial prostatitis are under 50 years of age and have no obstructive symptomatology, prophylactic low-dosage, continuous antimicrobial therapy to prevent recurrent bladder infections is almost 100% effective. While almost any antimicrobial agent to which the infecting organism is sensitive will serve as effective prophylaxis, one-half tablet of TMP-SMX is extremely efficacious. When the infecting organism is Pseudomonas aeruginosa, 250 mg of tetracycline hydrochloride is the least expensive and most useful agent because of the bactericidal levels of tetracycline in the urine. Most patients, when offered the alternative of low-dosage, single-tablet prophylaxis with the assurance that they can be kept completely asymptomatic, rarely choose the option of prostatectomy unless there are additional reasons for the surgery.
